Verified Treatment Center
Chase Brexton Healthcare Glen Burnie Center
Glen Burnie, MD · 21061
Key Takeaways for Chase Brexton Healthcare Glen Burnie Center
- • IOP · MAT · Dual Dx offered
- • Accepts Medicaid, Medicare, Private insurance, TRICARE/VA
- • Joint Commission accredited · SAMHSA-listed facility
- • Direct line available · Helpline free & confidential 24/7
About Chase Brexton Healthcare Glen Burnie Center
Chase Brexton Healthcare Glen Burnie Center is a SAMHSA-registered addiction-treatment facility located at Glen Burnie, MD. The facility offers a continuum of care across multiple levels — IOP, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. Patient-level evaluation of this facility should distinguish three considerations: state licensure status, voluntary accreditation (CARF or Joint Commission), and clinical-framework alignment with current ASAM Criteria — each of which is independently verifiable.
Care levels at Chase Brexton Healthcare Glen Burnie Center
The facility offers a continuum of care across multiple levels — IOP, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. Operational prerequisite for admission: documented clinical assessment establishing medical necessity for the specific level of care Chase Brexton Healthcare Glen Burnie Center provides. The ASAM Criteria 4e framework is the benchmark standard for this assessment and is referenced in most major payer medical-necessity documents.
Insurance and payment
Payment and insurance posture: Chase Brexton Healthcare Glen Burnie Center accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The facility also accepts TRICARE or military benefits. Pre-admission Verification of Benefits (VOB) documentation should include: specific plan product and network status, deductible status at time of admission, coinsurance rate applicable, prior authorization status and turnaround, and out-of-pocket accumulation. Under MHPAEA 2024 disclosure rules, plan-specific medical-necessity criteria must be available on request.
Specialty programming
The facility's documented specialty programming includes: Young adults, Adult women, Criminal justice (other than DUI/DWI)/Forensic clients. Clinical verification of specialty programming should encompass credentialed staff profile, programming-hour documentation, and specialty-specific medical-necessity documentation for third-party authorization. The MHPAEA 2024 rule addresses specialty-program network adequacy for patients requiring specific clinical capabilities.
Before you call
Operational admission checklist for Chase Brexton Healthcare Glen Burnie Center: (a) clinical assessment with documented ASAM 4e level-of-care recommendation; (b) insurance benefits verification in writing; (c) MAT policy documentation; (d) accreditation and licensure verification; (e) confirmed prior authorization for specific level of care. Each should be obtained in written form prior to admission. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.
Listing sourced from the SAMHSA Behavioral Health Treatment Services Locator. Data last synced April 2026. Verify current programs directly with the facility.
Chase Brexton Healthcare Glen Burnie Center at a Glance
Levels of care
IOP · MAT · Dual Dx
Service settings
Outpatient, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
Therapy approaches
Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Matrix Model, Relapse prevention
Age groups
Young Adults, Adults
Special populations
Young adults, Adult women, Criminal justice (other than DUI/DWI)/Forensic clients, Clients with co-occurring mental and substance use disorders, Clients with co-occurring pain and substance use disorders, Clients with HIV or AIDS
Medications
Acamprosate (Campral®), Disulfiram, Buprenorphine with naloxone, Buprenorphine without naloxone, Naltrexone (oral), Naltrexone (extended-release, injectable)
Insurance & Payment Accepted
Confirm in-network status before admission — verification is free.
Medicaid
Coverage details →Medicare
Coverage details →Private insurance
Coverage details →TRICARE / VA
Coverage details →Contact & Location
Address
200 Hospital Drive, Glen Burnie, MD 21061
Facility direct line
410-837-2050 x8800Website
www.chasebrexton.org